Depletion of Tregs for adoptive T-cell therapy using CD44 and CD137 as selection markers
Depletion of Tregs for adoptive T-cell therapy using CD44 and CD137 as selection markers
About this item
Full title
Author / Creator
Publisher
London: Future Medicine Ltd
Journal title
Language
English
Formats
Publication information
Publisher
London: Future Medicine Ltd
Subjects
More information
Scope and Contents
Contents
Several types of cancer have been shown to be susceptible to cellular immune responses, leading to investigations using various forms of T cell-based, tumor-directed immunotherapy. One potential obstacle for the successful application of these therapies is the suppressive function of Tregs. Goldstein and colleagues evaluate a strategy to identify a...
Alternative Titles
Full title
Depletion of Tregs for adoptive T-cell therapy using CD44 and CD137 as selection markers
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3390965
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3390965
Other Identifiers
ISSN
1750-743X
E-ISSN
1750-7448
DOI
10.2217/imt.12.33
